A folyamatos szubkután glükózmonitorizálás szerepe az intenzív terápiában

Translated title of the contribution: Role of continuous subcutaneous glucose monitoring in intensive care

Gábor Marics, Levente Koncz, A. Körner, Borbála Mikos, Péter Tóth-Heyn

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Critical care associated with stress hyperglycaemia has gained a new view in the last decade since the demonstration of the beneficial effects of strong glycaemic control on the mortality in intensive care units. Strong glycaemic control may, however, induce hypoglycaemia, resulting in increased mortality, too. Pediatric population has an increased risk of hypoglycaemia because of the developing central nervous system. In this view there is a strong need for close monitoring of glucose levels in intensive care units. The subcutaneous continuous glucose monitoring developed for diabetes care is an alternative for this purpose instead of regular blood glucose measurements. It is important to know the limitations of subcutaneous continuous glucose monitoring in intensive care. Decreased tissue perfusion may disturb the results of subcutaneous continuous glucose monitoring, because the measurement occurs in interstitial fluid. The routine use of subcutaneous continuous glucose monitoring in intensive care units is not recommended yet until sufficient data on the reliability of the system are available. The Medtronic subcutaneous continuous glucose monitoring system is evaluated in the review partly based on the authors own results.

Original languageHungarian
Pages (from-to)1043-1048
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number27
DOIs
Publication statusPublished - Jul 1 2013

Fingerprint

Critical Care
Glucose
Intensive Care Units
Hypoglycemia
Mortality
Extracellular Fluid
Hyperglycemia
Blood Glucose
Central Nervous System
Perfusion
Pediatrics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A folyamatos szubkután glükózmonitorizálás szerepe az intenzív terápiában. / Marics, Gábor; Koncz, Levente; Körner, A.; Mikos, Borbála; Tóth-Heyn, Péter.

In: Orvosi Hetilap, Vol. 154, No. 27, 01.07.2013, p. 1043-1048.

Research output: Contribution to journalArticle

Marics, Gábor ; Koncz, Levente ; Körner, A. ; Mikos, Borbála ; Tóth-Heyn, Péter. / A folyamatos szubkután glükózmonitorizálás szerepe az intenzív terápiában. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 27. pp. 1043-1048.
@article{b0ee6aac6cf3487d9b03e2dab5f786ed,
title = "A folyamatos szubkut{\'a}n gl{\"u}k{\'o}zmonitoriz{\'a}l{\'a}s szerepe az intenz{\'i}v ter{\'a}pi{\'a}ban",
abstract = "Critical care associated with stress hyperglycaemia has gained a new view in the last decade since the demonstration of the beneficial effects of strong glycaemic control on the mortality in intensive care units. Strong glycaemic control may, however, induce hypoglycaemia, resulting in increased mortality, too. Pediatric population has an increased risk of hypoglycaemia because of the developing central nervous system. In this view there is a strong need for close monitoring of glucose levels in intensive care units. The subcutaneous continuous glucose monitoring developed for diabetes care is an alternative for this purpose instead of regular blood glucose measurements. It is important to know the limitations of subcutaneous continuous glucose monitoring in intensive care. Decreased tissue perfusion may disturb the results of subcutaneous continuous glucose monitoring, because the measurement occurs in interstitial fluid. The routine use of subcutaneous continuous glucose monitoring in intensive care units is not recommended yet until sufficient data on the reliability of the system are available. The Medtronic subcutaneous continuous glucose monitoring system is evaluated in the review partly based on the authors own results.",
keywords = "CGM, Continuous glucose monitoring, Hyperglycaemia, Hyperglykaemia, Hypoglycaemia, Hypoglykaemia, Intensive care, Intenz{\'i}v ter{\'a}pia, Sz{\"o}veti gl{\"u}k{\'o}z monitoriz{\'a}l{\'a}sa",
author = "G{\'a}bor Marics and Levente Koncz and A. K{\"o}rner and Borb{\'a}la Mikos and P{\'e}ter T{\'o}th-Heyn",
year = "2013",
month = "7",
day = "1",
doi = "10.1556/OH.2013.29662",
language = "Hungarian",
volume = "154",
pages = "1043--1048",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "27",

}

TY - JOUR

T1 - A folyamatos szubkután glükózmonitorizálás szerepe az intenzív terápiában

AU - Marics, Gábor

AU - Koncz, Levente

AU - Körner, A.

AU - Mikos, Borbála

AU - Tóth-Heyn, Péter

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Critical care associated with stress hyperglycaemia has gained a new view in the last decade since the demonstration of the beneficial effects of strong glycaemic control on the mortality in intensive care units. Strong glycaemic control may, however, induce hypoglycaemia, resulting in increased mortality, too. Pediatric population has an increased risk of hypoglycaemia because of the developing central nervous system. In this view there is a strong need for close monitoring of glucose levels in intensive care units. The subcutaneous continuous glucose monitoring developed for diabetes care is an alternative for this purpose instead of regular blood glucose measurements. It is important to know the limitations of subcutaneous continuous glucose monitoring in intensive care. Decreased tissue perfusion may disturb the results of subcutaneous continuous glucose monitoring, because the measurement occurs in interstitial fluid. The routine use of subcutaneous continuous glucose monitoring in intensive care units is not recommended yet until sufficient data on the reliability of the system are available. The Medtronic subcutaneous continuous glucose monitoring system is evaluated in the review partly based on the authors own results.

AB - Critical care associated with stress hyperglycaemia has gained a new view in the last decade since the demonstration of the beneficial effects of strong glycaemic control on the mortality in intensive care units. Strong glycaemic control may, however, induce hypoglycaemia, resulting in increased mortality, too. Pediatric population has an increased risk of hypoglycaemia because of the developing central nervous system. In this view there is a strong need for close monitoring of glucose levels in intensive care units. The subcutaneous continuous glucose monitoring developed for diabetes care is an alternative for this purpose instead of regular blood glucose measurements. It is important to know the limitations of subcutaneous continuous glucose monitoring in intensive care. Decreased tissue perfusion may disturb the results of subcutaneous continuous glucose monitoring, because the measurement occurs in interstitial fluid. The routine use of subcutaneous continuous glucose monitoring in intensive care units is not recommended yet until sufficient data on the reliability of the system are available. The Medtronic subcutaneous continuous glucose monitoring system is evaluated in the review partly based on the authors own results.

KW - CGM

KW - Continuous glucose monitoring

KW - Hyperglycaemia

KW - Hyperglykaemia

KW - Hypoglycaemia

KW - Hypoglykaemia

KW - Intensive care

KW - Intenzív terápia

KW - Szöveti glükóz monitorizálása

UR - http://www.scopus.com/inward/record.url?scp=84880374280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880374280&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29662

DO - 10.1556/OH.2013.29662

M3 - Article

VL - 154

SP - 1043

EP - 1048

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 27

ER -